UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Comprehensive Income	Retained Earnings	Total
Equity Balance, value at Dec. 31, 2017	$ 37	$ 809	$ (8,341)	$ 85,617	$ 78,122
Equity Balance, shares at Dec. 31, 2017	3,721
Common stock issued upon exercise of employee stock options	$ 0	372	0	0	372
Common stock issued upon exercise of employee stock options, shares	9
Common stock received and retired upon exercise of stock options	$ 0	(225)	0	0	(225)
Common stock received and retired upon exercise of stock options, shares	(2)
Stock option compensation expense	$ 0	30	0	0	30
Foreign currency translation adjustment	0	0	1,301	0	1,301
Common stock dividends	0	0	0	(1,006)	(1,006)
Net income	0	0	0	4,092	4,092
Equity Balance, value at Mar. 31, 2018	$ 37	986	(7,040)	88,703	82,687
Equity Balance, shares at Mar. 31, 2018	3,728
Equity Balance, value at Dec. 31, 2017	$ 37	809	(8,341)	85,617	78,122
Equity Balance, shares at Dec. 31, 2017	3,721
Common stock purchased and retired					0
Foreign currency translation adjustment					(1,535)
Net income					8,400
Equity Balance, value at Jun. 30, 2018	$ 37	1,197	(9,876)	92,004	83,362
Equity Balance, shares at Jun. 30, 2018	3,732
Equity Balance, value at Mar. 31, 2018	$ 37	986	(7,040)	88,703	82,687
Equity Balance, shares at Mar. 31, 2018	3,728
Common stock issued upon exercise of employee stock options	$ 0	200	0	0	200
Common stock issued upon exercise of employee stock options, shares	4
Stock option compensation expense	$ 0	11	0	0	11
Foreign currency translation adjustment	0	0	(2,836)	0	(2,836)
Common stock dividends	0	0	0	(1,008)	(1,008)
Net income	0	0	0	4,308	4,308
Equity Balance, value at Jun. 30, 2018	$ 37	1,197	(9,876)	92,004	83,362
Equity Balance, shares at Jun. 30, 2018	3,732
Equity Balance, value at Dec. 31, 2018	$ 37	121	(11,290)	100,123	88,991
Equity Balance, shares at Dec. 31, 2018	3,720
Common stock issued upon exercise of employee stock options	$ 0	97	0	0	97
Common stock issued upon exercise of employee stock options, shares	3
Stock option compensation expense	$ 0	28	0	0	28
Foreign currency translation adjustment	0	0	948	0	948
Common stock dividends	0	0	0	(1,028)	(1,028)
Net income	0	0	0	3,139	3,139
Equity Balance, value at Mar. 31, 2019	$ 37	246	(10,343)	102,234	92,175
Equity Balance, shares at Mar. 31, 2019	3,723
Equity Balance, value at Dec. 31, 2018	$ 37	121	(11,290)	100,123	88,991
Equity Balance, shares at Dec. 31, 2018	3,720
Common stock purchased and retired					(398)
Foreign currency translation adjustment					484
Net income					6,664
Equity Balance, value at Jun. 30, 2019	$ 37	0	(10,807)	104,682	93,912
Equity Balance, shares at Jun. 30, 2019	3,719
Equity Balance, value at Mar. 31, 2019	$ 37	246	(10,343)	102,234	92,175
Equity Balance, shares at Mar. 31, 2019	3,723
Common stock issued upon exercise of employee stock options	$ 0	74	0	0	74
Common stock issued upon exercise of employee stock options, shares	1
Stock option compensation expense	$ 0	28	0	0	28
Common stock purchased and retired	$ 0	(348)	0	(50)	(398)
Common stock purchased and retired, shares	(5)
Foreign currency translation adjustment	$ 0	0	(464)	0	(464)
Common stock dividends	0	0	0	(1,028)	(1,028)
Net income	0	0	0	3,525	3,525
Equity Balance, value at Jun. 30, 2019	$ 37	$ 0	$ (10,807)	$ 104,682	$ 93,912
Equity Balance, shares at Jun. 30, 2019	3,719